The authors present a technique by gaining direct needle access retrograde into the proximal SFA occlusion using extravascular ultrasound with the goal of both increasing the probability of success and shortening procedural time.
The authors present a technique by gaining direct needle access retrograde into the proximal SFA occlusion using extravascular ultrasound with the goal of both increasing the probability of success and shortening procedural time.
Although there is no well-defined treatment method for PSA-related lesions, in this case, endovascular management proved to be a feasible, relatively easy, and durable option.
Although there is no well-defined treatment method for PSA-related lesions, in this case, endovascular management proved to be a feasible, relatively easy, and durable option.
This case report describes arterial recoiling as an indication for stent placement in a case of symptomatic FMD affecting the right external iliac artery.
This case report describes arterial recoiling as an indication for stent placement in a case of symptomatic FMD affecting the right external iliac artery.
The authors report the first use of the CorPath GRX Robotic System for assistance during balloon angioplasty and stenting for the treatment of severe bilateral renal artery stenosis.
The authors report the first use of the CorPath GRX Robotic System for assistance during balloon angioplasty and stenting for the treatment of severe bilateral renal artery stenosis.
Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.
Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.
The authors present a newly developed, wireless technology platform that enables physicians to control viewing and manipulation of images in the sterile operative space.
The authors present a newly developed, wireless technology platform that enables physicians to control viewing and manipulation of images in the sterile operative space.
The authors present a newly developed, wireless technology platform that enables physicians to control viewing and manipulation of images in the sterile operative space.
The authors present a newly developed, wireless technology platform that enables physicians to control viewing and manipulation of images in the sterile operative space.
Krievins and colleagues describe the successful management of a patient with CLI and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary CT angiogram and FFRCT assessment.
Krievins and colleagues describe the successful management of a patient with CLI and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary CT angiogram and FFRCT assessment.
Krievins and colleagues describe the successful management of a patient with critical limb ischemia and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary computed tomography angiogram and...
Krievins and colleagues describe the successful management of a patient with critical limb ischemia and femoral pseudoaneurysm who was found to have severe silent coronary ischemia by pre-operative coronary computed tomography angiogram and...
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
This study describes the results in the healing of venous ulcers with the perilesional and intralesional use of nepidermin in patients with a class VI venous insufficiency diagnosis.
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA
▪ Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patients
▪ Trial...
Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA
▪ Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patients
▪ Trial...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...
Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced today that the first...
Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced today that the first...
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
